STOCK TITAN

Canopy Growth Corp Stock Price, News & Analysis

CGC Nasdaq

Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.

Canopy Growth Corporation (CGC) is a global leader in cannabis production and consumer goods innovation. This news hub provides investors and industry observers with official press releases, financial updates, and strategic developments from one of the sector's most diversified companies.

Access real-time updates on CGC's medicinal cannabis research, recreational product launches, and international market expansions. Our curated collection includes earnings reports, partnership announcements, and regulatory compliance milestones across Canada, Europe, and U.S. markets through Canopy USA.

Key focus areas include vaporizer technology advancements, brand portfolio growth, and cultivation process innovations. Users will find detailed information on THC and CBD product developments, sustainability initiatives, and strategic moves in emerging cannabis markets.

Bookmark this page for direct access to verified CGC announcements. Check regularly for updates on clinical trials, retail partnerships, and operational developments that shape the company's position in the global cannabis industry.

Rhea-AI Summary

Canopy Growth Corporation has agreed to divest its subsidiary, C³ Cannabinoid Compound Company GmbH, to Dermapharm Holding SE for an upfront payment of EUR80M (approx. CAD$115.5M) and potential earnout payments up to EUR42.6M (approx. CAD$61.4M). This strategic sale allows Canopy Growth to focus on its core consumer packaged goods model, reducing operational complexities and capital investment requirements by over CAD$50M. The transaction is expected to close by January 31, 2022, with all C³ employees remaining with Dermapharm.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
none
-
Rhea-AI Summary

Beatrice Society has announced the formation of its Board of Directors, appointing Gary Yeoman as Chairman. The board includes seasoned professionals Lorne Gertner and Krisztián Tóth. Yeoman, previously at Voxtur Analytics and Altus Group, aims to build on recent acquisitions in psychedelics and wellness. Gertner co-founded Cannasat Therapeutics and has notable ties to the cannabis industry, while Tóth specializes in corporate finance. The board's expertise is expected to strengthen Beatrice's position in the growing psychedelic therapy market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.35%
Tags
management
-
Rhea-AI Summary

On November 19, 2021, Canopy Growth announced critical changes in its Executive Management Committee. Mike Lee, Chief Financial Officer, and Rade Kovacevic, Chief Product Officer, will depart by December 31, 2021. Judy Hong and Tara Rozalowsky have been appointed as interim CFO and Chief Product Officer, respectively. CEO David Klein emphasized that these changes aim to enhance the company’s long-term growth and shareholder value. Canopy Growth continues to pursue its strategic priorities while maintaining its leadership position in the cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
Rhea-AI Summary

Canopy Growth Corporation (CGC) reported financial results for Q2 FY2022, ending September 30, 2021. Net revenue was $131.4 million, a 3% decline from Q2 FY2021, with cannabis revenue rising 1% to $95 million. The company announced plans to acquire Wana Brands, enhancing its U.S. presence. Gross margin dropped to -54%, impacted by inventory write-downs of $87 million, while adjusted EBITDA loss widened to $163 million. Despite challenges, Canopy remains optimistic about U.S. growth, aiming to stabilize Canadian operations and enhance product distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.09%
Tags
-
Rhea-AI Summary

On October 28, 2021, Martha Stewart CBD announced the release of new CBD products, including the permanent Harvest Medley CBD Wellness Gummies and limited-edition Mini CBD Peppermint Ribbons and Snowflake CBD Gummy Sampler for the holiday season. The brand has exceeded initial projections and is the fastest-growing CBD brand, with a 20% quarter-over-quarter growth. The Harvest Medley Gummies feature popular flavors like Green Apple, Concord Grape, and Pomegranate. These products aim to enhance wellness while celebrating Martha Stewart's commitment to making CBD accessible.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
none
-
Rhea-AI Summary

Canopy Growth Corporation (CGC) will announce its financial results for the second quarter of fiscal year 2022, ending September 30, 2021, on November 5, 2021, before market open. The company's executive team, including CEO David Klein and CFO Mike Lee, will host an audio webcast at 10:00 AM ET on the same day to discuss the results. Canopy Growth, a leading cannabis company, continues to expand its portfolio and market presence, including partnerships with major brands and growth in health and wellness sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.7%
Tags
conferences earnings
Rhea-AI Summary

Canopy Growth Corporation has announced its agreement to acquire Wana Brands, the leading cannabis edibles brand in North America, upon federal legalization of THC in the U.S. This strategic move, valued at USD 297.5 million, aims to enhance Canopy's presence in the U.S. cannabis market, which is expected to expand significantly. Wana operates in 12 U.S. states and has plans to reach more than 20 states by the end of 2022. The acquisition is seen as a pivotal step in Canopy's growth strategy, leveraging Wana's established brand and profitable business model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.09%
Tags
-
Rhea-AI Summary

Karma Water has launched its first CBD beverage, Karma CBD Water, in collaboration with Canopy Growth Corporation. This innovative drink combines 25mg of CBD distillate made from U.S. hemp with Karma's patented Push Cap technology, designed to preserve potency until consumption. Available in five natural flavors, the product aims to cater to the growing demand for quick-acting wellness beverages. Distributed through Constellation Brands' beer network, Karma CBD Water is positioned to strengthen both companies' market presence in the CBD category.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.58%
Tags
none
-
Rhea-AI Summary

On September 14, 2021, Canopy Growth Corporation (NASDAQ: CGC) held its annual general and special meeting where 66.01% of issued shares were voted. All proposals in the proxy statement were approved by the majority. Key results included the election of directors with high support, such as Judy A. Schmeling with 98.59% votes in favor, and the appointment of KPMG LLP as auditors for fiscal year 2022. The shareholders also approved amendments to the Company’s By-laws and an advisory resolution on executive compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
none
Rhea-AI Summary

Canopy Growth Corporation has launched its first CBD vape, whisl, available for purchase on ShopCanopy.com and at over 3,000 Circle K stores nationwide starting October 1. This nicotine-free vaporizer features interchangeable pods tailored for focus, relaxation, and sleep, each containing 200 mg of premium CBD isolate. The MSRP for the starter kit is $39.99, and each pod package is priced at $19.99. Designed for immediate effects, whisl aims to enhance mood management while ensuring quality and safety through rigorous testing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.79%
Tags
none

FAQ

What is the current stock price of Canopy Growth (CGC)?

The current stock price of Canopy Growth (CGC) is $1.27 as of May 5, 2025.

What is the market cap of Canopy Growth (CGC)?

The market cap of Canopy Growth (CGC) is approximately 209.3M.
Canopy Growth Corp

Nasdaq:CGC

CGC Rankings

CGC Stock Data

209.31M
156.12M
0.14%
6.27%
8.85%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS